FDA announces new guidelines for monkeypox vaccine
On August 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new way of administering the Jynneos vaccine for those at high risk for monkeypox infection. The EUA allows healthcare providers to use the vaccine by intradermal injection for individuals 18 years …continue reading